These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12101253)

  • 1. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
    Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
    Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
    Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
    Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
    Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman L; Peterlin BM
    Int Immunol; 2003 Apr; 15(4):467-75. PubMed ID: 12663676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations and interactions between bare lymphocyte syndrome factors.
    DeSandro AM; Nagarajan UM; Boss JM
    Mol Cell Biol; 2000 Sep; 20(17):6587-99. PubMed ID: 10938133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly of functional regulatory complexes on MHC class II promoters in vivo.
    Fontes JD; Jabrane-Ferrat N; Peterlin BM
    J Mol Biol; 1997 Jul; 270(3):336-45. PubMed ID: 9237901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
    Scholl T; Mahanta SK; Strominger JL
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
    Brickey WJ; Wright KL; Zhu XS; Ting JP
    J Immunol; 1999 Dec; 163(12):6622-30. PubMed ID: 10586057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.
    Nekrep N; Jabrane-Ferrat N; Peterlin BM
    Mol Cell Biol; 2000 Jun; 20(12):4455-61. PubMed ID: 10825209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.
    Jabrane-Ferrat N; Fontes JD; Boss JM; Peterlin BM
    Mol Cell Biol; 1996 Sep; 16(9):4683-90. PubMed ID: 8756625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hierarchy of nuclear localization signals governs the import of the regulatory factor X complex subunits and MHC class II expression.
    Nagarajan UM; Long AB; Harreman MT; Corbett AH; Boss JM
    J Immunol; 2004 Jul; 173(1):410-9. PubMed ID: 15210800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).
    Steimle V; Durand B; Barras E; Zufferey M; Hadam MR; Mach B; Reith W
    Genes Dev; 1995 May; 9(9):1021-32. PubMed ID: 7744245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression.
    Garvie CW; Stagno JR; Reid S; Singh A; Harrington E; Boss JM
    Biochemistry; 2007 Feb; 46(6):1597-611. PubMed ID: 17279624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RFX family interacts at the collagen (COL1A2) start site and represses transcription.
    Sengupta PK; Fargo J; Smith BD
    J Biol Chem; 2002 Jul; 277(28):24926-37. PubMed ID: 11986307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
    Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
    J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.